Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Marchetti

Showing results (51-60 of 187) with videos related to

Pageof 19
Sort By:
Clinical Drug Investigation|September 19, 2019
Reduction of Immune Activation and Partial Recovery of Staphylococcal Enterotoxin B-Induced Cytokine Production After Switching to an Integrase Strand Transfer Inhibitor-Containing Regimen: Results from an Observational Cohort StudyEsther Merlini, Federico A Cazzaniga, Anna Casabianca, et al.
Antiviral Therapy|July 21, 2004
IL-7/IL-7 receptor system regulation following IL-2 immunotherapy in HIV-infected patientsGiulia Marchetti, Luca Meroni, Chiara Molteni, et al.
Annals of Clinical and Laboratory Science|September 1, 2019
T-Cell Subsets (T<sub>CM</sub>, T<sub>EM</sub>, T<sub>EMRA</sub>) and Poly-Functional Immune Response in Patients with Human Immunodeficiency Virus (HIV) Infection and Different T-CD4 Cell ResponseSerena Meraviglia, Paola Di Carlo, Diego Pampinella, et al.
HIV Clinical Trials|August 22, 2014
Efficacy and safety of darunavir/ritonavir plus etravirine dual regimen in antiretroviral therapy-experienced patients: a multicenter clinical experienceLidia Gazzola, Paola Cicconi, Diego Ripamonti, et al.
Plos One|April 24, 2025
In vivo assessment of the effect of gel containing lactic acid and glycogen on vaginal microbiota and pH of asymptomatic women of reproductive ageAdriana Bittencourt Campaner, Ana Carolina Alves Rosário Sica, Flavia Salomão d' Avila Curi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 10, 2016
Brief Report: Soluble CD163 in CMV-Infected and CMV-Uninfected Subjects on Virologically Suppressive Antiretroviral Therapy in the ICONA CohortSerena Vita, Miriam Lichtner, Giulia Marchetti, et al.
Journal of Translational Medicine|March 2, 2013
Association between peripheral T-Lymphocyte activation and impaired bone mineral density in HIV-infected patientsLidia Gazzola, Giusi Maria Bellistri, Camilla Tincati, et al.
AIDS (London, England)|September 12, 2008
Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapyGiulia Marchetti, Giusi M Bellistrì, Elisa Borghi, et al.
Antiviral Therapy|September 11, 2015
T-cell phenotype and function following a first cART regimen containing either a protease inhibitor or a non-nucleoside reverse transcriptase inhibitor in HIV-infected late presenters: results from a retrospective, ex vivo studyCamilla Tincati, Alessia Savoldi, E Stefania Cannizzo, et al.
Current HIV Research|June 22, 2012
Immune reconstitution in HIV+ subjects on lopinavir/ritonavir-based HAART according to the severity of pre-therapy CD4+Giulia Marchetti, Esther Merlini, Elisabetta Sinigaglia, et al.
Pageof 19

Showing results (51-60 of 187) with videos related to

Sort By:
Pageof 19
Clinical Drug Investigation|September 19, 2019
Reduction of Immune Activation and Partial Recovery of Staphylococcal Enterotoxin B-Induced Cytokine Production After Switching to an Integrase Strand Transfer Inhibitor-Containing Regimen: Results from an Observational Cohort StudyEsther Merlini, Federico A Cazzaniga, Anna Casabianca, et al.
Antiviral Therapy|July 21, 2004
IL-7/IL-7 receptor system regulation following IL-2 immunotherapy in HIV-infected patientsGiulia Marchetti, Luca Meroni, Chiara Molteni, et al.
Annals of Clinical and Laboratory Science|September 1, 2019
T-Cell Subsets (T<sub>CM</sub>, T<sub>EM</sub>, T<sub>EMRA</sub>) and Poly-Functional Immune Response in Patients with Human Immunodeficiency Virus (HIV) Infection and Different T-CD4 Cell ResponseSerena Meraviglia, Paola Di Carlo, Diego Pampinella, et al.
HIV Clinical Trials|August 22, 2014
Efficacy and safety of darunavir/ritonavir plus etravirine dual regimen in antiretroviral therapy-experienced patients: a multicenter clinical experienceLidia Gazzola, Paola Cicconi, Diego Ripamonti, et al.
Plos One|April 24, 2025
In vivo assessment of the effect of gel containing lactic acid and glycogen on vaginal microbiota and pH of asymptomatic women of reproductive ageAdriana Bittencourt Campaner, Ana Carolina Alves Rosário Sica, Flavia Salomão d' Avila Curi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 10, 2016
Brief Report: Soluble CD163 in CMV-Infected and CMV-Uninfected Subjects on Virologically Suppressive Antiretroviral Therapy in the ICONA CohortSerena Vita, Miriam Lichtner, Giulia Marchetti, et al.
Journal of Translational Medicine|March 2, 2013
Association between peripheral T-Lymphocyte activation and impaired bone mineral density in HIV-infected patientsLidia Gazzola, Giusi Maria Bellistri, Camilla Tincati, et al.
AIDS (London, England)|September 12, 2008
Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapyGiulia Marchetti, Giusi M Bellistrì, Elisa Borghi, et al.
Antiviral Therapy|September 11, 2015
T-cell phenotype and function following a first cART regimen containing either a protease inhibitor or a non-nucleoside reverse transcriptase inhibitor in HIV-infected late presenters: results from a retrospective, ex vivo studyCamilla Tincati, Alessia Savoldi, E Stefania Cannizzo, et al.
Current HIV Research|June 22, 2012
Immune reconstitution in HIV+ subjects on lopinavir/ritonavir-based HAART according to the severity of pre-therapy CD4+Giulia Marchetti, Esther Merlini, Elisabetta Sinigaglia, et al.
Pageof 19